February, 2020 | PharmaShots

Insights+ Exclusive: COVID-19 Healthcare News Updates

February 28, 2020April 24, 2020Shiwani Sharma

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 [Read More...]

Companion Medical’s InPen Diabetes Management System Receives the US FDA’s Approval for Fixed Dosing and Meal Estimation

February 28, 2020February 28, 2020Tuba Khan

Shots: The InPen bolus calculator determines the user’s current glucose level and active insulin to calculate the amount of insulin still lowering glucose [Read More...]

Insights+ Interviews: Impact of new regulations and trends in the medical device industry in India – interviews of Dr. Bina Naik and Dr. Ashish Indani during DIA Medical Device Conference 2020

February 28, 2020February 28, 2020Shiwani Sharma

The Medical Devices Conference was hosted by DIA India on 21st and 22nd February in collaboration with the Medical Technology Association of India [Read More...]

Takeda’s Vedolizumab SC Receives CHMP’s Positive Opinion as a Maintenance Therapy for Moderately to Severely Active UC or CD

February 28, 2020February 28, 2020Tuba Khan

Shots: The CHMP’s positive opinion is based on P-III VISIBLE study assessing vedolizumab (SC) as maintenance therapy vs PBO in ~1000 patients with [Read More...]

Gates Foundation Forms an Alliance with Global Pharma Companies to Develop PAN-TB Drug Regimen for Tuberculosis

February 28, 2020February 28, 2020Tuba Khan

Shots: GSK, Evotec, J&J, Otsuka, the Bill & Melinda Gates Medical Research Institute and its foundation have launched the ‘PAN-TB collaboration’ project to [Read More...]

Fujifilm’s CAD EYE Receives CE Mark to Support the Detection of Colonic Polyp Utilizing AI in the EU

February 28, 2020February 28, 2020Tuba Khan

Shots: Fujifilm’s CAD EYE receives CE mark, backing the real-time detection of colonic polyps during colonoscopy utilizing AI, will be available with software [Read More...]

GSK Reports Submission of NDA to MHLW for Daprodustat to Treat Patients with Renal Anaemia due to Chronic Kidney Disease in Japan

GSK’s Advil Dual Action in Combination with Acetaminophen Receives the US FDA’s Approval for Pain Relief

February 28, 2020March 26, 2020Shiwani Sharma

Shots: The approval is based on seven clinical studies including three of which were pivotal efficacy and safety studies in pain relief which [Read More...]

Boehringer Ingelheim Collaborates with Trutino Biosciences to Develop New Therapies Utilizing On-Demand-Cytokine Platform

February 28, 2020February 28, 2020Tuba Khan

Shots: Trutino to receive upfront, pre/ clinical milestones, regulatory and commercial milestones along with royalties on sales. Boehringer to get access for Trutino’s [Read More...]

Baysient to Release iDose Software Technology Platform 1.0 to Reduce the Biosimilar Cost in Market

February 28, 2020March 6, 2020Shiwani Sharma

The 12-month clinical validation study (NCT02453776) data demonstrated the reduction “switching” from lower cost infliximab to more expensive biologics by 66%. Also, similar [Read More...]

Biogen Signs an Exclusive Worldwide License Agreement with Sangamo to Develop Gene Therapies for Multiple Neurological Diseases

February 28, 2020February 28, 2020Tuba Khan

Shots: Sangamo to receive $350 million upfront, including $125M license fee & $225M equity investment in Sangamo’s stock or ~24M shares at $9.21/share [Read More...]